Park J, Espinosa Cotton M, Guo H, Monette S, Cheung N. Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. J Immunother Cancer. 2023;11: pubmed publisher

Qing G, Zhiyuan W, Jinge Y, Yuqing M, Zuoguan C, Yongpeng D, et al. Single-Cell RNA Sequencing Revealed CD14+ Monocytes Increased in Patients With Takayasu's Arteritis Requiring Surgical Management. Front Cell Dev Biol. 2021;9:761300 pubmed publisher

Lee E, Szvetecz S, Polli R, Grauel A, Chen J, Judge J, et al. PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer. Sci Rep. 2021;11:14841 pubmed publisher

Hoseini S, Vadlamudi M, Espinosa Cotton M, Tran H, Feng Y, Guo H, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9: pubmed publisher

Taylor H, Calantone N, Lichon D, Hudson H, Clerc I, Campbell E, et al. mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport. Cell Rep. 2020;31:107810 pubmed publisher

Taylor H, Calantone N, D Aquila R. mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research. AIDS. 2018;32:2847-2851 pubmed publisher

Dockry E, O Leary S, Gleeson L, Lyons J, Keane J, Gray S, et al. Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells. Oncoimmunology. 2018;7:e1428156 pubmed publisher

Yuan Z, Kang G, Daharsh L, Fan W, Li Q. SIVcpz closely related to the ancestral HIV-1 is less or non-pathogenic to humans in a hu-BLT mouse model. Emerg Microbes Infect. 2018;7:59 pubmed publisher

Loiseau C, Requena M, Mavigner M, Cazabat M, Carrere N, Suc B, et al. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016;9:1137-50 pubmed publisher

Søgaard O, Graversen M, Leth S, Olesen R, Brinkmann C, Nissen S, et al. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. PLoS Pathog. 2015;11:e1005142 pubmed publisher

Bryn T, Mahic M, Enserink J, Schwede F, Aandahl E, Tasken K. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J Immunol. 2006;176:7361-70 pubmed